Analyst Recommendations

39.27 -0.35(-0.87%)10/04/2024
Mirum Pharmaceuticals Inc (MIRM)


2024: Total Recommendations Consensus
To Grade# of Recommendations
Buy14
Overweight7
Outperform5
Market Outperform4

5 records were shown. To view all data, Upgrade to PRO plan with only $1


Upgrades & Downgrades